Stevens Capital Management’s AngioDynamics ANGO Stock Holding History

Stevens Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,018	Closed	-$167K	–	728
2017 Q4	$167K	Buy	+10,018	New	+$171K	0.01%	751
2017 Q3	–	Sell	-24,488	Closed	-$397K	–	836
2017 Q2	$397K	Buy	24,488 +188	+0.8%	+$2.97K	0.01%	624
2017 Q1	$422K	Buy	24,300 +4,133	+20%	+$69.1K	0.02%	622
2016 Q4	$340K	Buy	+20,167	New	+$336K	0.01%	658
2015 Q3	–	Sell	-12,365	Closed	-$203K	–	965
2015 Q2	$203K	Sell	12,365 -2,939	-19%	-$48.8K	0.01%	878
2015 Q1	$272K	Buy	+15,304	New	+$284K	0.01%	774
2014 Q2	–	Sell	-10,061	Closed	-$158K	–	1044
2014 Q1	$158K	Buy	+10,061	New	+$164K	﹤0.01%	961

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Stevens Capital Management's ANGO Position: Q1 2018 in Review

Stevens Capital Management sold out of AngioDynamics (ANGO) in Q1 2018, closing a stake of 10,018 shares — an estimated $167K sold.

Stevens Capital Management first reported a position in ANGO in Q1 2014 and held it in 7 quarters. The position peaked at $422K in Q1 2017. 164 funds tracked by Wall St. Rank hold ANGO as of Q1 2018.

Stevens Capital Management reported no remaining AngioDynamics position as of Q1 2018 after selling out during the quarter.
Stevens Capital Management sold 10,018 AngioDynamics shares in Q1 2018, an estimated $167K.
Stevens Capital Management first reported a position in AngioDynamics in Q1 2014 and held it in 7 quarters.
Stevens Capital Management's AngioDynamics position peaked at $422K in Q1 2017.
164 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2018.

Based on Stevens Capital Management's 13F filing for Q1 2018, filed 8 May 2018.